🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › California › Irvine

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Irvine, CA

6 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Irvine (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Nagre-recruitPhase 3
  • Kaiser Permanente-Irvine, Irvine
Edad 65 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07321652

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Nagre-recruitPhase 3
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • Kaiser Permanente-Irvine, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04269902

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nagre-recruitPhase 3
  • Kaiser Permanente Southern California, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06973187

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Nagre-recruitPhase 2
  • City of Hope at Irvine Lennar, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07061951

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Nagre-recruitPhase 2
  • City of Hope National Medical Center, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update May 19, 2026 · NCT06588478

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Nagre-recruitPhase 2
  • City of Hope at Irvine Lennar, Irvine
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT07218510

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Irvine

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.